Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Blackledge

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of ifosfamide in cervical cancerC A Meanwell, J J Mould, G Blackledge, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma GroupW P Steward, H T Mouridsen, P Kerbrat, et al.
Cancer|February 1, 1988
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factorsW P Steward, D Crowther, L J McWilliam, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancerT J Perren, R N Clayton, G Blackledge, et al.
Lancet (London, England)|February 16, 1985
Encephalopathy associated with ifosphamide/mesna therapyC A Meanwell, A E Blake, T N Latief, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]H Akaza, K Aiba, S Isonishi, et al.
European Journal of Cancer|November 1, 1980
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)G Blackledge, H Bush, J Chang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Comparison of management of advanced cancer in various organs]H Akaza, T Saeki, K Kawai, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Doxorubicin plus ifosfamide with rhGM-CSF in the treatment of advanced adult soft-tissue sarcomas: preliminary results of a phase II study from the EORTC Soft-Tissue and Bone Sarcoma GroupW P Steward, J Verweij, R Somers, et al.
Cancer Treatment Reports|June 1, 1986
Phase II study of ifosfamide in cervical cancerC A Meanwell, J J Mould, G Blackledge, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1989
Phase II trial of methylene dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adult. A study of the EORTC Soft Tissue and Bone Sarcoma GroupW P Steward, H T Mouridsen, P Kerbrat, et al.
Cancer|February 1, 1988
Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. A randomized prospective study with an assessment of prognostic factorsW P Steward, D Crowther, L J McWilliam, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancerT J Perren, R N Clayton, G Blackledge, et al.
Lancet (London, England)|February 16, 1985
Encephalopathy associated with ifosphamide/mesna therapyC A Meanwell, A E Blake, T N Latief, et al.
British Journal of Cancer|June 1, 1984
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma groupH Anderson, D P Deakin, J Wagstaff, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Development of molecular targeting drugs for the treatment of cancer-therapeutic potential and issues to be addressed in global development]H Akaza, K Aiba, S Isonishi, et al.
European Journal of Cancer|November 1, 1980
Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group)G Blackledge, H Bush, J Chang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 4, 2001
[Comparison of management of advanced cancer in various organs]H Akaza, T Saeki, K Kawai, et al.
Pageof 10